Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.

Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L.

J Clin Oncol. 2012 Dec 20;30(36):4584-6; author reply 4588-9. doi: 10.1200/JCO.2012.44.1022. Epub 2012 Nov 19. No abstract available.

PMID:
23169510
2.

Considerations in the development of circulating tumor cell technology for clinical use.

Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli M, Deisseroth A, Hayes DF, Kapke G, Kumar P, Lee JSh, Liu MC, McCormack R, Mikulski S, Nagahara L, Pantel K, Pearson-White S, Punnoose EA, Roadcap LT, Schade AE, Scher HI, Sigman CC, Kelloff GJ.

J Transl Med. 2012 Jul 2;10:138. doi: 10.1186/1479-5876-10-138. Review.

3.
4.

Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720.

Kharel Y, Lee S, Snyder AH, Sheasley-O'neill SL, Morris MA, Setiady Y, Zhu R, Zigler MA, Burcin TL, Ley K, Tung KS, Engelhard VH, Macdonald TL, Pearson-White S, Lynch KR.

J Biol Chem. 2005 Nov 4;280(44):36865-72. Epub 2005 Aug 10.

6.
7.

P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow.

Xia L, Sperandio M, Yago T, McDaniel JM, Cummings RD, Pearson-White S, Ley K, McEver RP.

J Clin Invest. 2002 Apr;109(7):939-50.

8.

Proto-oncogene Sno expression, alternative isoforms and immediate early serum response.

Pearson-White S, Crittenden R.

Nucleic Acids Res. 1997 Jul 15;25(14):2930-7.

9.

Expression of basic helix-loop-helix transcription factors in explant hematopoietic progenitors.

Quesenberry PJ, Iscove NN, Cooper C, Brady G, Newburger PE, Stein GS, Stein JS, Reddy GP, Pearson-White S.

J Cell Biochem. 1996 Jun 1;61(3):478-88.

PMID:
8761952
10.

The ski/sno protooncogene family in hematopoietic development.

Pearson-White S, Deacon D, Crittenden R, Brady G, Iscove N, Quesenberry PJ.

Blood. 1995 Sep 15;86(6):2146-55.

11.

SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno.

Pearson-White S.

Nucleic Acids Res. 1993 Sep 25;21(19):4632-8.

12.

Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice.

Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ.

Blood. 1993 May 15;81(10):2566-71.

13.

Ectopic expression of MyoD1 in mice causes prenatal lethalities.

Faerman A, Pearson-White S, Emerson C, Shani M.

Dev Dyn. 1993 Mar;196(3):165-73.

14.

Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene.

Dekel I, Magal Y, Pearson-White S, Emerson CP, Shani M.

New Biol. 1992 Mar;4(3):217-24.

PMID:
1581290
15.

The consequences of a constitutive expression of MyoD1 in ES cells and mouse embryos.

Shani M, Faerman A, Emerson CP, Pearson-White S, Dekel I, Magal Y.

Symp Soc Exp Biol. 1992;46:19-36.

PMID:
1341036
16.

Human MyoD: cDNA and deduced amino acid sequence.

Pearson-White SH.

Nucleic Acids Res. 1991 Mar 11;19(5):1148. No abstract available.

17.

Myogenic lineage determination and differentiation: evidence for a regulatory gene pathway.

Pinney DF, Pearson-White SH, Konieczny SF, Latham KE, Emerson CP Jr.

Cell. 1988 Jun 3;53(5):781-93.

PMID:
3286015
19.

Closely related alpha-tropomyosin mRNAs in quail fibroblasts and skeletal muscle cells.

Hallauer PL, Hastings KE, Baldwin AS, Pearson-White S, Merrifield PA, Emerson CP Jr.

J Biol Chem. 1987 Mar 15;262(8):3590-6.

20.

Isolation of mutants of an animal virus in bacteria.

Peden KW, Pipas JM, Pearson-White S, Nathans D.

Science. 1980 Sep 19;209(4463):1392-6.

PMID:
6251547

Supplemental Content

Loading ...
Support Center